New formulations of oxybutynin have been introduced ... OXY-IR is effective in controlling detrusor overactivity at an oral dose of 5 mg three or four times daily. 4 With OXY-ER, there is an ...
who were randomly assigned to receive either solifenacin (5 mg once daily; n = 68) or oxybutynin (5 mg three times daily; n = 64) for 8 weeks. The primary outcome measure was the patient ...
Dosing ranges from 15 to 30 mg every 6 to 8 hours. The drug has strong anticholinergic side effects. Although it was available before oxybutynin, it has one of the highest side effect profiles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback